Dr. Michael V. Como, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York Downstate Medical Center (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 967
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: State University of New York Downstate Medical Center
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
NY license 210616
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- North Shore University Hospital Manhasset, NY
- St Francis Hospital - the Heart Center Roslyn, NY
- Mercy Medical Center Rockville Centre, NY
- Chsli St Joseph Hospital Bethpage, NY
Medical groups
- Chs Physician PArtners PC (743 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 967
- Services billed
- 4,415
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 639 | 305 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 549 | 260 |
| Established patient office or other outpatient visit, 30-39 minutes | 357 | 236 |
| Test to measure expiratory airflow and volume | 349 | 252 |
| X-ray of chest, 1 view | 321 | 214 |
| Critical care, first 30-74 minutes | 295 | 126 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 187 | 177 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 163 | 156 |
| Test to determine lung volumes using sensors | 150 | 133 |
| Test to examine how well the lungs exchange gases | 150 | 133 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Great Neck, NY | 375 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Great Neck, NY | 219 |
| Prednisone Other prescribers in Great Neck, NY | 139 |
| Azithromycin Other prescribers in Great Neck, NY | 105 |
| Fluticasone Propionate Other prescribers in Great Neck, NY | 75 |
| Montelukast Sodium Other prescribers in Great Neck, NY | 64 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Great Neck, NY | 62 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Great Neck, NY | 51 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Great Neck, NY | 50 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Great Neck, NY | 42 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 24 companies reported 141 payments worth $11,060 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $7,759 |
|---|---|
| GlaxoSmithKline, LLC. | $609 |
| Atricure, Inc. | $491 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $307 |
| Verona Pharma, Inc. | $194 |
| Actelion Pharmaceuticals US, Inc. | $175 |
| Cvrx, Inc. | $164 |
| Genzyme Corporation | $160 |
| Consulting Fee | $5,580 |
|---|---|
| Food and Beverage | $4,277 |
| Travel and Lodging | $885 |
| Compensation for services other than consulting (speaking, faculty) | $300 |
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Sep 21, 2025 | Consulting Fee BREZTRI · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 20, 2025 | Consulting Fee | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 24, 2025 | Consulting Fee FASENRA · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $318 |
| AstraZeneca Pharmaceuticals LP Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) BREZTRI · Respiratory Company’s descriptionSpeaker Fee | $300 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $284 |
| AstraZeneca Pharmaceuticals LP Sep 24, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX Company’s descriptionConsulting Expenses | $226 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $57.61 |
| Insmed, Inc. Oct 28, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.